Valuation : Pharmaids Pharmaceuticals Limited

Market Cap 112.79Cr 1.19Cr 1.03Cr 97.03L 88.41L 1.65Cr 1.66Cr 11Cr 4.46Cr 58Cr 4.48Cr 4.39Cr 189.42Cr P/E 2025
-22.5x
P/E 2026 -8.33x
Enterprise Value 139.19Cr 1.47Cr 1.27Cr 1.2Cr 1.09Cr 2.04Cr 2.05Cr 14Cr 5.5Cr 71Cr 5.53Cr 5.41Cr 233.77Cr EV / Sales 2025
14.5x
EV / Sales 2026 4.45x
Free-Float
25.74%
Yield 2025 *
-
Yield 2026 -
12/08 Pharmaids Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
29/05 Pharmaids Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
12/02 Pharmaids Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
05/01 Pharmaids Pharmaceuticals Limited Announces Completion of Term of Mopperthy Sudheer as Independent Director and Member of the Audit Committee and Nomination & Remuneration Committee, Effective January 5, 2026 CI
02/01 Pharmaids Pharmaceuticals Limited Appoints Dr. Yogananda Moolemath as Independent Director, Effective January 1, 2026 CI
28/11 Pharmaids Pharmaceuticals appoints P N Vijay as chairman effective December 5, 2025 RE
28/11 Pharmaids Pharmaceuticals Limited Announces Board and Committee Changes CI
11/11 Pharmaids Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025 CI
18/25/18 Sourabh Hadimani completed the acquisition of 66.50% stake in Anugraha Chemicals P. Ltd. from Pharmaids Pharmaceuticals Limited. CI
18/25/18 Shankarappa Nagaraja Vinaya Babu completed the acquisition of 7.68% stake in Pharmaids Pharmaceuticals Limited for approximately INR 170 million. CI
07/25/07 Pharmaids Pharmaceuticals Limited Announces Executive Changes, Effective August 7, 2025 CI
07/25/07 Pharmaids Pharmaceuticals Limited Announces Resignation of S Prasad as the Chief Executive Officer Effective August 07, 2025 CI
07/25/07 Pharmaids Pharmaceuticals CEO S Prasad resigns RE
1 day+2.96%
1 week-0.96%
Current month+0.60%
1 month+0.98%
3 months+17.66%
6 months-8.26%
Current year-32.90%
1 week 30.1
Extreme 30.1
33.97
1 month 29.2
Extreme 29.2
36.8
Current year 25.6
Extreme 25.6
50.9
1 year 25.6
Extreme 25.6
66
3 years 25.6
Extreme 25.6
87.46
5 years 10.17
Extreme 10.17
87.46
10 years 2.15
Extreme 2.15
87.46
Manager TitleAgeSince
Director of Finance/CFO - 13/10/2022
Chief Tech/Sci/R&D Officer - 07/08/2025
Compliance Officer - 14/08/2024
Director TitleAgeSince
Chairman 75 05/12/2025
Director/Board Member - 29/08/2023
Chairman 50 31/01/2024
Change 5-day change 1-year change 3-year change Capi.($)
+2.96%-0.96%-47.55%-18.06% 1.16Cr
-0.49%-2.43%+55.53%+105.59% 1,03400Cr
+0.67%+3.83%+55.03%+71.74% 66TCr
-0.72%+0.31%+22.23%+77.24% 46TCr
+2.39%-2.14%+32.17%+38.25% 34TCr
+0.10%+5.01%+26.97%+47.01% 31TCr
+1.34%-0.18%-0.97%+13.12% 25TCr
+0.07%+0.80%+55.18%+73.41% 24TCr
+0.20%+1.73%-17.63%-54.17% 21TCr
+0.01%+0.13%+31.92%+98.32% 19TCr
Average +0.55%-0.35%+21.29%+45.24% 36.93TCr
Weighted average by Cap. +0.15%-0.62%+37.58%+67.14%

Financials

2025 2026
Net sales 19Cr 20.59L 17.76L 16.73L 15.24L 28.49L 28.71L 1.98Cr 76.87L 9.94Cr 77.31L 75.62L 33Cr 28Cr 29.52L 25.46L 23.99L 21.86L 40.85L 41.16L 2.84Cr 1.1Cr 14Cr 1.11Cr 1.08Cr 47Cr
Net income -11Cr -11.41L -10L -9L -8L -15.79L -15.91L -1.1Cr -42.6L -5.51Cr -42.84L -41.9L -18Cr -12Cr -12.4L -10.7L -10.08L -9L -17.17L -17.3L -1.19Cr -46.31L -5.99Cr -46.58L -45.56L -20Cr
Net Debt 40Cr 42.22L 36.42L 34.31L 31.26L 58.43L 58.87L 4.06Cr 1.58Cr 20Cr 1.59Cr 1.55Cr 67Cr 26Cr 27.95L 24.11L 22.72L 20.7L 38.69L 38.98L 2.69Cr 1.04Cr 13Cr 1.05Cr 1.03Cr 44Cr
Logo Pharmaids Pharmaceuticals Limited
Pharmaids Pharmaceuticals Limited is an India-based suppliers of a range of specialty chemicals, skin care, hospital care and generic products in the areas of orthopedic, neuro and gastro, and other. The Company is engaged in the business of trading and manufacturing of generics, bulk drugs, and intermediaries, and other. The Company operates through Bulk Drugs and Intermediates segment. Its specialty chemicals products include Retinol, DL Alpha Tocopherol, D Pantothenate, Cyanocobalamin, Pyridoxine Hcl, Thiamine, Nicotinic Acid, Water Sol. Vitamin E, Coenzyme Q10 and D-Biotin. Its skin care products include Best care hands, Hands Sanitizer, Moisturizing Cream, Skinsure Plus, SkinSure Ultra, Alcohol Gel and Barrier Cream. Its hospital care products include Xepi Rub M, Facein Spray, Sod Hypochlorite, Sanmedin, Strumen G, Strumen TRIACID, Facein Eco, Facein Power 256, Facein Spray, Sod Hypochlorite, Wipes and PPE. Its generic products include Linzomust, Benfoshine, Duojoint, and other.
Employees
127
Date Price Change Volume
03/26/03 31.98 +2.96% 2,415
02/26/02 ₹31.06 -4.11% 1,814
01/26/01 ₹32.39 +1.89% 2,272
31/26/31 ₹31.79 -0.59% 5,437
28/26/28 ₹31.98 -0.96% 2,743
  1. Stock Market
  2. Stocks
  3. PHARMAID Stock